Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 2 | 2021 | 356 | 1.100 |
Why?
|
| Neoplasms | 2 | 2025 | 809 | 0.940 |
Why?
|
| Exosomes | 2 | 2024 | 96 | 0.910 |
Why?
|
| Interleukins | 1 | 2025 | 112 | 0.870 |
Why?
|
| Nanomedicine | 2 | 2021 | 62 | 0.870 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 225 | 0.800 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2021 | 30 | 0.730 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 405 | 0.720 |
Why?
|
| Lung Diseases | 1 | 2021 | 43 | 0.700 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 465 | 0.690 |
Why?
|
| Retinoblastoma | 1 | 2020 | 8 | 0.680 |
Why?
|
| Retinal Neoplasms | 1 | 2020 | 8 | 0.680 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 679 | 0.660 |
Why?
|
| Up-Regulation | 1 | 2020 | 246 | 0.630 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 215 | 0.610 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 453 | 0.600 |
Why?
|
| Dental Caries | 1 | 2012 | 22 | 0.380 |
Why?
|
| Dentin | 1 | 2012 | 12 | 0.380 |
Why?
|
| Drug Resistance, Fungal | 1 | 2012 | 16 | 0.380 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2012 | 42 | 0.370 |
Why?
|
| Humans | 10 | 2025 | 28097 | 0.280 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 459 | 0.270 |
Why?
|
| MicroRNAs | 2 | 2021 | 301 | 0.230 |
Why?
|
| Signal Transduction | 2 | 2021 | 1435 | 0.220 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 86 | 0.190 |
Why?
|
| Drug Carriers | 1 | 2023 | 115 | 0.190 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2021 | 26 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 155 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 60 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 79 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 198 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 107 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 135 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2021 | 193 | 0.160 |
Why?
|
| Cell Cycle | 1 | 2020 | 161 | 0.160 |
Why?
|
| Animals | 2 | 2025 | 10423 | 0.160 |
Why?
|
| Disease Progression | 1 | 2020 | 473 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 589 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2020 | 806 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1319 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 5 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2016 | 17 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 8 | 0.130 |
Why?
|
| Melanoma | 1 | 2016 | 141 | 0.110 |
Why?
|
| Root Caries | 1 | 2012 | 1 | 0.100 |
Why?
|
| Actinomyces | 1 | 2012 | 4 | 0.100 |
Why?
|
| Chlorhexidine | 1 | 2012 | 7 | 0.100 |
Why?
|
| Dental Pulp Cavity | 1 | 2012 | 5 | 0.100 |
Why?
|
| Lactobacillus | 1 | 2012 | 14 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 10 | 0.090 |
Why?
|
| Amphotericin B | 1 | 2012 | 19 | 0.090 |
Why?
|
| RNA | 2 | 2022 | 110 | 0.090 |
Why?
|
| Candida albicans | 1 | 2012 | 48 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 148 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2012 | 67 | 0.090 |
Why?
|
| Poverty | 1 | 2012 | 89 | 0.090 |
Why?
|
| Female | 5 | 2024 | 15156 | 0.090 |
Why?
|
| Sex Factors | 1 | 2012 | 466 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 167 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 734 | 0.080 |
Why?
|
| Young Adult | 2 | 2016 | 2733 | 0.070 |
Why?
|
| Adolescent | 2 | 2016 | 3122 | 0.070 |
Why?
|
| Smoking | 1 | 2012 | 473 | 0.070 |
Why?
|
| Risk Factors | 1 | 2012 | 2081 | 0.060 |
Why?
|
| Aged | 2 | 2016 | 5400 | 0.060 |
Why?
|
| Middle Aged | 2 | 2016 | 7138 | 0.060 |
Why?
|
| Adult | 2 | 2016 | 7740 | 0.050 |
Why?
|
| DNA Damage | 1 | 2022 | 151 | 0.050 |
Why?
|
| Transcriptome | 1 | 2022 | 214 | 0.040 |
Why?
|
| Male | 2 | 2016 | 13491 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 632 | 0.040 |
Why?
|
| Monosomy | 1 | 2016 | 1 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 14 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 34 | 0.030 |
Why?
|
| India | 1 | 2016 | 142 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 194 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 165 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 659 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 887 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 1013 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 1146 | 0.020 |
Why?
|